Distinguished in Eosinophilic Asthma

Monique A. Henket

CHU Liège
Liege, WAL, BE 
Distinguished in Eosinophilic Asthma
CHU Liège
Liege, WAL, BE 
OverviewLocationsClinical Research

Overview

Monique Henket practices in Liege, Belgium. Ms. Henket is rated as a Distinguished expert by MediFind in the treatment of Eosinophilic Asthma. Her top areas of expertise are Eosinophilic Asthma, Asthma, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Eosinophilic Asthma.

Gender
Female

Locations

CHU Liège
Liege, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Assessment of the Impact of a Dietary Supplement Synbiotic Probiotical ®/Bactecal® in Asthma
Assessment of the Impact of a Dietary Supplement Synbiotic Probiotical ®/Bactecal® in Asthma
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Dietary supplement, Other
Study Phase: Phase 2/Phase 3
Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics
Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics
Enrollment Status: Completed
Publish Date: May 11, 2017
Intervention Type: Other
Study Phase: Phase 4
View 1 Less Clinical Trial

73 Total Publications

Transcriptomics in T2-High Severe Asthmatics Treated with Biologics: Comparison Between Anti-IgE, Anti-IL-5 and Anti-IL-5R-Targeted Treatments.
Transcriptomics in T2-High Severe Asthmatics Treated with Biologics: Comparison Between Anti-IgE, Anti-IL-5 and Anti-IL-5R-Targeted Treatments.
Journal: American journal of respiratory cell and molecular biology
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Henket's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile